相关实验视频

Updated: Jul 12, 2026

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

27.8K

在患有恶性质瘤的孕妇中使用gliadel:一个病例报告

Vishnu Venkitasubramony1, Meghan Tahbaz2, Kian A Huang1

  • 1Morsani College of Medicine, University of South Florida, Tampa, FL, United States.

Frontiers in oncology
|November 17, 2025
PubMed
概括

本案例研究探讨了在怀孕期间使用内溶性卡姆斯片治疗恶性质瘤的方法. 这种方法在最小的胎儿暴露下显示出可行性,尽管患者最终进展.

关键词:
滑翔的晶圆片 滑翔的晶圆片卡尔姆斯蒂纳 (carmustine) 是一种葡萄酒.案例报告案例报告恶性质瘤是一种恶性质瘤.怀孕 怀孕 怀孕 怀孕 怀孕

更多相关视频

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells05:29

A Rapid Screening Workflow to Identify Potential Combination Therapy for GBM using Patient-Derived Glioma Stem Cells

Published on: March 28, 2021

3.1K
Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment09:02

Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment

Published on: September 27, 2024

3.0K

相关概念视频

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...